Description
.stl-pdp{
–c-logo:#062021;
–c-deep:#081c17;
–c-forest:#0a3721;
–c-green:#0ea43c;
–c-lime:#91c72e;
–c-grey:#e0e0e0;
–c-white:#ffffff;
–c-ink:#0d2a22;
–c-mut:#52635c;
–c-line:#e3e9e6;
–c-line-d:rgba(255,255,255,.14);
–c-mut-d:#aebfb7;
max-width:1000px;margin:0 auto;color:var(–c-ink);
font-family:”Helvetica Neue”,Arial,system-ui,-apple-system,Segoe UI,Roboto,sans-serif;
line-height:1.6;-webkit-font-smoothing:antialiased;
}
.stl-pdp *{box-sizing:border-box}
.stl-pdp h2,.stl-pdp h3{letter-spacing:-.02em;line-height:1.15;color:var(–c-logo)}
.stl-pdp h2{font-size:clamp(1.5rem,3.4vw,2.1rem);font-weight:800;margin:0 0 .5rem}
.stl-pdp h3{font-size:1.18rem;font-weight:800;margin:0 0 .35rem}
.stl-pdp p{margin:0 0 1rem}
.stl-pdp .eyebrow{display:inline-block;font-size:.74rem;font-weight:800;letter-spacing:.14em;
text-transform:uppercase;color:var(–c-green);margin-bottom:.7rem}
.stl-pdp .eyebrow–lime{color:var(–c-lime)}
.stl-pdp a{color:var(–c-green);text-decoration:underline;text-underline-offset:2px;font-weight:600}
.stl-pdp section{padding:46px 4px}
.stl-pdp section + section{border-top:1px solid var(–c-line)}
.stl-pdp .stl-btn{display:inline-block;background:var(–c-green);color:#fff;text-decoration:none;font-weight:800;
font-size:.95rem;padding:13px 24px;border-radius:11px;transition:transform .15s,background .18s;border:0;cursor:pointer}
.stl-pdp .stl-btn:hover{background:#0bbf45;color:#fff;transform:translateY(-1px)}
.stl-grid4{display:grid;grid-template-columns:repeat(4,1fr);gap:14px}
.stl-chip{background:var(–c-white);border:1px solid var(–c-line);border-radius:14px;padding:20px 18px}
.stl-chip svg{width:26px;height:26px;color:var(–c-green);margin-bottom:10px}
.stl-chip b{display:block;color:var(–c-logo);font-size:.98rem;margin-bottom:3px}
.stl-chip span{font-size:.86rem;color:var(–c-mut)}
.stl-spec{background:#fff;border:1px solid var(–c-line);border-radius:18px;overflow:hidden;color:var(–c-ink);
box-shadow:0 1px 2px rgba(6,32,33,.04),0 14px 40px rgba(10,55,33,.08)}
.stl-spec__tabs{display:flex;gap:4px;background:#f1f6f3;padding:7px;flex-wrap:wrap;border-bottom:1px solid var(–c-line)}
.stl-spec__tab{appearance:none;border:0;background:transparent;cursor:pointer;font:inherit;font-weight:700;
font-size:.92rem;color:var(–c-mut);padding:11px 18px;border-radius:10px;transition:background .18s,color .18s;
flex:1 1 auto;min-width:120px;text-align:center}
.stl-spec__tab:hover{color:var(–c-logo)}
.stl-spec__tab[aria-selected=”true”]{background:var(–c-forest);color:#fff;box-shadow:0 3px 12px rgba(10,55,33,.28)}
.stl-spec__tab:focus-visible{outline:3px solid var(–c-green);outline-offset:2px}
.stl-spec__panel{padding:28px clamp(20px,3vw,34px) 34px}
.stl-spec__panel[hidden]{display:none}
.stl-spec__table{width:100%;border-collapse:collapse;font-size:.95rem}
.stl-spec__table caption{text-align:left;font-weight:800;color:var(–c-logo);font-size:1.06rem;padding-bottom:16px}
.stl-spec__table th,.stl-spec__table td{text-align:left;padding:13px 4px;border-bottom:1px solid var(–c-line);vertical-align:top}
.stl-spec__table tr:last-child th,.stl-spec__table tr:last-child td{border-bottom:0}
.stl-spec__table th{width:38%;font-weight:700;color:var(–c-ink)}
.stl-spec__table td{color:var(–c-mut)}
.stl-spec__table tbody tr:hover{background:#f6faf8}
.stl-spec__table sub{font-size:.72em}
.stl-spec__table + .stl-spec__table{margin-top:30px}
.stl-seq{font-family:ui-monospace,SFMono-Regular,Menlo,Consolas,monospace;font-size:13px;word-break:break-word;line-height:1.55}
.stl-copy{display:inline-flex;align-items:center;gap:8px;flex-wrap:wrap}
.stl-copy__btn{appearance:none;border:1px solid var(–c-line);background:#fff;border-radius:7px;
cursor:pointer;font:inherit;font-size:.74rem;font-weight:700;color:var(–c-green);padding:3px 9px;transition:background .15s,border-color .15s}
.stl-copy__btn:hover{background:#f1f6f3;border-color:var(–c-green)}
.stl-copy__btn:focus-visible{outline:2px solid var(–c-green);outline-offset:1px}
.stl-copy__btn[data-copied=”1″]{color:#fff;background:var(–c-green);border-color:var(–c-green)}
.stl-trust{display:grid;gap:13px}
.stl-trust__row{display:flex;gap:13px;align-items:flex-start;padding:15px 17px;background:#f4f8f5;border-radius:12px}
.stl-trust__ic{flex:0 0 auto;width:22px;height:22px;color:var(–c-green);margin-top:1px}
.stl-trust__row b{color:var(–c-logo)}
.stl-trust__row p{margin:4px 0 0;font-size:.9rem;color:var(–c-mut)}
.stl-pill{display:inline-block;background:var(–c-lime);color:#062021;font-size:.76rem;font-weight:800;padding:3px 11px;border-radius:999px;margin-left:8px;vertical-align:middle}
.stl-spec h3{color:var(–c-logo)}
.stl-spec .stl-sub{color:var(–c-mut);font-size:.92rem;margin:0 0 18px}
.stl-list{list-style:none;margin:0;padding:0;display:grid;gap:12px}
.stl-list li{display:flex;gap:12px;align-items:flex-start;font-size:.94rem;color:var(–c-ink)}
.stl-list li b{color:var(–c-logo)}
.stl-list svg{flex:0 0 auto;width:18px;height:18px;color:var(–c-green);margin-top:3px}
.stl-spec a.stl-btn{margin-top:20px}
.stl-coa{margin:6px 0 24px}
.stl-coa img{display:block;width:100%;height:auto;border:1px solid var(–c-line);border-radius:12px;background:#fff}
.stl-coa figcaption{font-size:.84rem;color:var(–c-mut);margin-top:8px}
.stl-coa-head{display:flex;align-items:center;flex-wrap:wrap;margin:26px 0 10px}
.stl-coa-head h3{margin:0}
.stl-comp{display:grid;grid-template-columns:repeat(3,1fr);gap:16px;margin-top:8px}
.stl-comp__card{background:#fff;border:1px solid var(–c-line);border-radius:14px;padding:22px 20px}
.stl-comp__card h3{margin:0 0 4px}
.stl-comp__tag{display:inline-block;font-size:.72rem;font-weight:800;letter-spacing:.04em;color:var(–c-green);
text-transform:uppercase;margin-bottom:10px}
.stl-comp__card p{margin:0;font-size:.92rem;color:var(–c-mut)}
.stl-feat{display:grid;grid-template-columns:1fr 1fr;gap:14px 30px;margin-top:8px}
.stl-feat div{display:flex;gap:11px;align-items:flex-start}
.stl-feat svg{flex:0 0 auto;width:19px;height:19px;color:var(–c-green);margin-top:3px}
.stl-feat b{color:var(–c-logo)}
.stl-feat p{margin:2px 0 0;font-size:.9rem;color:var(–c-mut)}
.stl-reg{background:var(–c-deep);color:#fff;border-radius:18px;padding:clamp(26px,4vw,40px)}
.stl-reg h2{color:#fff}
.stl-reg .eyebrow{color:var(–c-lime)}
.stl-reg__grid{display:grid;grid-template-columns:1fr 1fr;gap:14px;margin-top:18px}
.stl-reg__card{background:rgba(255,255,255,.05);border:1px solid var(–c-line-d);border-radius:12px;padding:18px 20px}
.stl-reg__card b{color:var(–c-lime);display:block;margin-bottom:5px;font-size:.95rem}
.stl-reg__card p{margin:0;font-size:.9rem;color:var(–c-grey)}
.stl-refs{font-size:.84rem;color:var(–c-mut);counter-reset:r;list-style:none;padding:0;margin:0;display:grid;gap:9px}
.stl-refs li{padding-left:30px;position:relative}
.stl-refs li::before{counter-increment:r;content:counter(r);position:absolute;left:0;top:0;
width:21px;height:21px;background:var(–c-forest);color:var(–c-lime);border-radius:6px;
font-size:.72rem;font-weight:800;display:flex;align-items:center;justify-content:center}
.stl-note{margin-top:8px;padding:16px 18px;border-left:4px solid var(–c-green);background:#f2f7f4;
border-radius:0 10px 10px 0;font-size:.85rem;color:var(–c-mut)}
.stl-note b{color:var(–c-logo)}
.stl-pdp–nojs .stl-spec__tabs{display:none}
.stl-pdp–nojs .stl-spec__panel[hidden]{display:block}
.stl-pdp–nojs .stl-spec__panel + .stl-spec__panel{border-top:1px solid var(–c-line)}
@media (max-width:760px){
.stl-grid4{grid-template-columns:1fr 1fr}
.stl-feat,.stl-reg__grid{grid-template-columns:1fr}
.stl-spec__table th{width:46%}
}
@media (max-width:880px){.stl-comp{grid-template-columns:1fr}}
@media (max-width:440px){.stl-grid4{grid-template-columns:1fr}}
@media (prefers-reduced-motion:reduce){.stl-pdp *{transition:none!important}}
.stl-pdp{font-size:16px}
.stl-pdp p,.stl-pdp li,.stl-pdp td,.stl-pdp th,.stl-pdp .stl-spec__table{font-size:16px;line-height:1.65}
.stl-pdp .stl-chip span,.stl-pdp .stl-sub,.stl-pdp .stl-feat p,.stl-pdp .stl-reg__card p,.stl-pdp .stl-trust__row p,.stl-pdp .stl-refs li,.stl-pdp .stl-note,.stl-pdp .stl-copy__btn,.stl-pdp .stl-btn,.stl-pdp .stl-spec__tab,.stl-pdp .stl-comp__card p{font-size:16px}
.stl-pdp h3{font-size:1.4rem}
.stl-pdp h2{font-size:clamp(2rem,3vw,2.5rem)}
.stl-pdp .eyebrow,.stl-pdp .eyebrow–lime,.stl-pdp .stl-comp__tag{font-size:14px}
.stl-pdp .stl-pill{font-size:14px}
.stl-pdp .stl-coa figcaption{font-size:14px}
.stl-pdp .stl-refs li::before{font-size:14px}
.stl-pdp .stl-spec__table sub{font-size:14px}
.stl-pdp .stl-spec__table caption{font-size:18px}
.stl-pdp .stl-seq{font-size:13px}
Key highlights
Three lyophilized vialsBPC-157 (5 mg), TB-500 (5 mg), and GHK-Cu (50 mg), each freeze-dried in a sterile glass vial.
99%+ HPLC purity, all threeEach compound independently analyzed by an accredited US third-party lab.
Cold-chain peptidesRefrigerate after reconstitution. Diluent and lab supplies not included.
Research use onlySupplied exclusively for laboratory investigation and development.
Product specifications
| Compound Class | Synthetic Pentadecapeptide (15 amino acids) · Derived from a sequence within Body Protection Compound (BPC) |
|---|---|
| Form | Lyophilized powder in sterile glass vial |
| Quantity | 5 mg per vial |
| CAS Number | 137525-51-0 |
| Chemical Formula | C62H98N16O22 |
| Molar Mass | 1,419.5 g/mol |
| Half-Life | ~4 hours |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Verified Purity | Batch-tested to 99.85% (HPLC) |
| Compound Class | Synthetic Polypeptide (43 amino acids) · Analog of thymosin β4 |
|---|---|
| Form | Lyophilized powder in sterile glass vial |
| Quantity | 5 mg per vial |
| CAS Number | 77591-33-4 |
| Chemical Formula | C212H350N56O78S |
| Molecular Weight | 4963.49 g/mol |
| Amino Acid Sequence | Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH |
| Verified Purity | Batch-tested to 99.42% (HPLC) |
| Compound Class | Tripeptide–copper(II) complex (Gly-His-Lys bound to copper) |
|---|---|
| Form | Lyophilized powder in sterile glass vial · blue-purple due to copper |
| Quantity | 50 mg per vial |
| CAS Number | 89030-95-5 |
| Chemical Formula | C14H22CuN6O4 |
| Molar Mass | ≈401.9 g/mol |
| Peptide Sequence | Gly-His-Lys (as a copper(II) complex) |
| Synonyms | GHK-Cu, Copper Tripeptide-1, Copper peptide, Glycyl-L-histidyl-L-lysine copper(II) |
| Verified Purity | Batch-tested to 99.97% (HPLC) |
For laboratory research use only. Not for human or animal consumption.
Independently verified
Each compound in this stack is analyzed by an accredited US third-party laboratory before it ships.
Identity and purity confirmed by MZ Biolabs (Tucson, AZ), a US DEA-licensed analytical facility, via HPLC purity analysis and mass-spectrometry identity confirmation under GLP standards.
Our third-party certificates of analysis are published on our website — no login required.
BPC-15799.85% pure
TB-500 (Thymosin β4)99.42% pure
GHK-Cu99.97% pure
Storage & handling
These compounds are photo- and temperature-sensitive; handle per standard laboratory practice.
- Lyophilized storage: Keep the sealed vials cool, dry, and protected from light. For longer-term storage, freezing is standard practice for lyophilized material.
- After reconstitution: Refrigerate (approximately 2–8 °C) and follow your institution’s SOPs for aliquoting, handling, and disposal. Avoid repeated freeze–thaw cycles.
- Diluent not included: Suitable laboratory diluent and reconstitution supplies are not provided with this product.
- UV-resistant glass vials to help protect photo-labile material during storage.
- Tamper-evident seals to support chain-of-custody and inventory controls.
Why source this stack from Sports Technology Labs
Quality control across the research-peptide industry is inconsistent, and many suppliers do not publish third-party testing for their products. Independent verification of identity and purity is essential for reproducible research.
All three compounds verified by MZ Biolabs (Tucson, AZ), an accredited US laboratory, via HPLC and mass spectrometry, with batch-linked COAs.
Each compound is freeze-dried into a sterile, UV-resistant glass vial.
Supports chain-of-custody, label transparency, and batch-linked traceability.
Transparent business, standard payment methods, no misrepresentation.
What is in the Glow Stack?
This stack, marketed as the “Glow Stack,” pairs three research compounds — BPC-157, TB-500, and GHK-Cu — supplied as separate lyophilized vials. The three are distinct molecules with different structures, described below by identity only.
BPC-157
A synthetic pentadecapeptide (15 amino acids) whose sequence corresponds to a partial fragment of Body Protection Compound (BPC), a protein identified in human gastric juice. Used as a research chemical to investigate this peptide in experimental models.
TB-500 (Thymosin β4)
A synthetic peptide analog of thymosin β4, a naturally occurring 43-amino-acid peptide. Thymosin β4 is characterized biochemically as an actin-sequestering peptide (it binds monomeric G-actin). Used as a research chemical to investigate thymosin β4 biology.
GHK-Cu
A tripeptide (Gly-His-Lys) that forms a coordination complex with copper(II), giving the characteristic blue-purple color. The tripeptide occurs naturally in human plasma. Used as a research chemical to investigate the GHK-copper complex in experimental models.
These compounds are supplied strictly as research chemicals for laboratory research. Sports Technology Labs makes no claims regarding their effects, and nothing in this listing should be interpreted as describing outcomes in humans or animals.
Important regulatory information
All three compounds are investigational research chemicals. They are not approved by the FDA and are not drugs, foods, dietary supplements, or cosmetics. Marketing them for human use is unlawful.
BPC-157 has no approval from any governmental regulatory health authority for human therapeutic use, and as such falls under WADA category S0 (Non-Approved Substances), prohibited at all times (ref. 4).
Thymosin β4 (TB-500) is associated with WADA category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), under growth factors affecting regenerative capacity. Athletes should consult the current WADA Prohibited List (ref. 4).
GHK-Cu is not currently listed on the World Anti-Doping Agency Prohibited List.
Sports Technology Labs are chemical suppliers, not medical providers. We do not condone or encourage consumer use of research compounds.
Scientific references
- Safer D, Nachmias VT. Beta thymosins as actin-binding peptides. BioEssays. 1994;16(7):473–479.
- Lau SJ, Sarkar B. The interaction of copper(II) and glycyl-L-histidyl-L-lysine, a tripeptide from plasma. Biochem J. 1981;199(3):649–656.
- National Center for Biotechnology Information. PubChem Compound Summaries for BPC-157 (CAS 137525-51-0), Thymosin β4 / TB-500 (CAS 77591-33-4), and GHK-Cu (CAS 89030-95-5): sequences, molecular formulae, and molecular weights. PubChem, National Library of Medicine.
- WADA Prohibited List (2025): Section S0 (Non-Approved Substances) and Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). WADA.org.
Research use only. All products on this website are intended exclusively for laboratory research and development. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.
FAQs On BPC-157, TB-500, and GHK-Cu Peptide
• BPC-157 (Body Protection Compound-157)
• TB-500 (Thymosin Beta-4 fragment)
• GHK-Cu (Copper peptide complex)
